BRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06

Reuters12-19 16:39

BRIEF-<a href="https://laohu8.com/S/ALVO">Alvotech</a> and <a href="https://laohu8.com/S/TEVA">Teva</a> Secure U.S. Settlement Date For AVT06

Dec 19 (Reuters) - Alvotech SA ALVO.O:

ALVOTECH AND TEVA SECURE U.S. SETTLEMENT DATE FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA®
ALVOTECH SA - LICENSE ENTRY DATE FOR AVT06 IN U.S. SET FOR Q4 2026

Source text: ID:nGNXbmfQ1S

Further company coverage: ALVO.O

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592154719?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-19 16:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592154719","market":"fut","top_or_hot":-1,"title":"BRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> and <a href=\"https://laohu8.com/S/TEVA\">Teva</a> Secure U.S. Settlement Date For AVT06</title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Alvotech SA <span>ALVO.O</span>:</p><ul><li><p>ALVOTECH AND TEVA SECURE U.S. SETTLEMENT DATE FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA®</p></li><li><p>ALVOTECH SA - LICENSE ENTRY DATE FOR AVT06 IN U.S. SET FOR Q4 2026</p></li></ul><p>Source text: <span>ID:nGNXbmfQ1S</span></p><p>Further company coverage: <span>ALVO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-19 16:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> and <a href=\"https://laohu8.com/S/TEVA\">Teva</a> Secure U.S. Settlement Date For AVT06</title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Alvotech SA <span>ALVO.O</span>:</p><ul><li><p>ALVOTECH AND TEVA SECURE U.S. SETTLEMENT DATE FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA®</p></li><li><p>ALVOTECH SA - LICENSE ENTRY DATE FOR AVT06 IN U.S. SET FOR Q4 2026</p></li></ul><p>Source text: <span>ID:nGNXbmfQ1S</span></p><p>Further company coverage: <span>ALVO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA5W8TV7:1","article_id":"2592154719","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592154719","pubTimestamp":1766133570,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06Dec 19 (Reuters) - Alvotech SA ALVO.O:ALVOTECH AND TEVA SECURE U.S. SETTLEMENT DATE FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEAALVOTECH SA - ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","ALVO":"Alvotech","BK4585":"ETF&股票定投概念","BK4557":"大麻股","TEVA":"梯瓦制药","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","BK4139":"生物科技","BK4584":"避孕概念","BK4596":"哈里斯概念","BK4559":"巴菲特持仓","BK4007":"制药","BK4566":"资本集团"},"translate_title":"简介-Alvotech和Teva确定AVT06在美国的结算日期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEVA":0.9,"ALVO":0.9},"content_text":"BRIEF-Alvotech and Teva Secure U.S. Settlement Date For AVT06Dec 19 (Reuters) - Alvotech SA ALVO.O:ALVOTECH AND TEVA SECURE U.S. SETTLEMENT DATE FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA®ALVOTECH SA - LICENSE ENTRY DATE FOR AVT06 IN U.S. SET FOR Q4 2026Source text: ID:nGNXbmfQ1SFurther company coverage: ALVO.O ((Reuters.Briefs@thomsonreuters.com;;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592154719","isCrawlerRequest":true}